95 related articles for article (PubMed ID: 9249998)
1. A phase I/II study of polymerized bovine hemoglobin in adult patients with sickle cell disease not in crisis at the time of study.
Gonzalez P; Hackney AC; Jones S; Strayhorn D; Hoffman EB; Hughes G; Jacobs EE; Orringer EP
J Investig Med; 1997 Jun; 45(5):258-64. PubMed ID: 9249998
[TBL] [Abstract][Full Text] [Related]
2. Hemoglobin-based oxygen carrier preserves submaximal exercise capacity in humans.
Hughes GS; Yancey EP; Albrecht R; Locker PK; Francom SF; Orringer EP; Antal EJ; Jacobs EE
Clin Pharmacol Ther; 1995 Oct; 58(4):434-43. PubMed ID: 7586936
[TBL] [Abstract][Full Text] [Related]
3. HBOC-201 vasoactivity in a phase III clinical trial in orthopedic surgery subjects--extrapolation of potential risk for acute trauma trials.
Freilich D; Pearce LB; Pitman A; Greenburg G; Berzins M; Bebris L; Ahlers S; McCarron R
J Trauma; 2009 Feb; 66(2):365-76. PubMed ID: 19204509
[TBL] [Abstract][Full Text] [Related]
4. Vasoactivity of bovine polymerized hemoglobin (HBOC-201) in swine with traumatic hemorrhagic shock with and without brain injury.
Rice J; Philbin N; Handrigan M; Hall C; McGwin G; Ahlers S; Pearce LB; Arnaud F; McCarron R; Freilich D
J Trauma; 2006 Nov; 61(5):1085-99. PubMed ID: 17099513
[TBL] [Abstract][Full Text] [Related]
5. When blood is not an option: factors affecting survival after the use of a hemoglobin-based oxygen carrier in 54 patients with life-threatening anemia.
Mackenzie CF; Moon-Massat PF; Shander A; Javidroozi M; Greenburg AG
Anesth Analg; 2010 Mar; 110(3):685-93. PubMed ID: 20042443
[TBL] [Abstract][Full Text] [Related]
6. Hematologic effects of a novel hemoglobin-based oxygen carrier in normal male and female subjects.
Hughes GS; Francome SF; Antal EJ; Adams WJ; Locker PK; Yancey EP; Jacobs EE
J Lab Clin Med; 1995 Nov; 126(5):444-51. PubMed ID: 7595029
[TBL] [Abstract][Full Text] [Related]
7. Bovine polymerized hemoglobin (hemoglobin-based oxygen carrier-201) resuscitation in three swine models of hemorrhagic shock with militarily relevant delayed evacuation--effects on histopathology and organ function.
Johnson T; Arnaud F; Dong F; Philbin N; Rice J; Asher L; Arrisueno M; Warndorf M; Gurney J; McGwin G; Kaplan L; Flournoy WS; Apple FS; Pearce LB; Ahlers S; McCarron R; Freilich D
Crit Care Med; 2006 May; 34(5):1464-74. PubMed ID: 16540964
[TBL] [Abstract][Full Text] [Related]
8. HBOC-201 as an alternative to blood transfusion: efficacy and safety evaluation in a multicenter phase III trial in elective orthopedic surgery.
Jahr JS; Mackenzie C; Pearce LB; Pitman A; Greenburg AG
J Trauma; 2008 Jun; 64(6):1484-97. PubMed ID: 18545113
[TBL] [Abstract][Full Text] [Related]
9. A hemoglobin-based oxygen carrier, bovine polymerized hemoglobin (HBOC-201) versus hetastarch (HEX) in a moderate severity hemorrhagic shock swine model with delayed evacuation.
Philbin N; Rice J; Gurney J; McGwin G; Arnaud F; Dong F; Johnson T; Flournoy WS; Ahlers S; Pearce LB; McCarron R; Freilich D
Resuscitation; 2005 Sep; 66(3):367-78. PubMed ID: 16081200
[TBL] [Abstract][Full Text] [Related]
10. Does HBOC-201 (Hemopure) affect platelet function in orthopedic surgery: a single-site analysis from a multicenter study.
Jahr JS; Liu H; Albert OK; Gull A; Moallempour M; Lim J; Gosselin R
Am J Ther; 2010; 17(2):140-7. PubMed ID: 19417588
[TBL] [Abstract][Full Text] [Related]
11. Low-volume resuscitation with a polymerized bovine hemoglobin-based oxygen-carrying solution (HBOC-201) provides adequate tissue oxygenation for survival in a porcine model of controlled hemorrhage.
York GB; Eggers JS; Smith DL; Jenkins DH; McNeil JD; Mueller D; Josephs JD; Kerby JD
J Trauma; 2003 Nov; 55(5):873-85. PubMed ID: 14608160
[TBL] [Abstract][Full Text] [Related]
12. Bovine polymerized hemoglobin versus Hextend resuscitation in a swine model of severe controlled hemorrhagic shock with delay to definitive care.
Rice J; Philbin N; McGwin G; Arnaud F; Johnson T; Flournoy WS; Pearce LB; McCarron R; Kaplan L; Handrigan M; Freilich D
Shock; 2006 Sep; 26(3):302-10. PubMed ID: 16912657
[TBL] [Abstract][Full Text] [Related]
13. Hemoglobin-based oxygen carrying compound-201 as salvage therapy for severe neuro- and polytrauma (Injury Severity Score = 27-41).
Dudkiewicz M; Harpaul TA; Proctor KG
Crit Care Med; 2008 Oct; 36(10):2838-48. PubMed ID: 18766094
[TBL] [Abstract][Full Text] [Related]
14. Hemoglobin oxygen saturation discrepancy using various methods in patients with sickle cell vaso-occlusive painful crisis.
Ahmed S; Siddiqui AK; Sison CP; Shahid RK; Mattana J
Eur J Haematol; 2005 Apr; 74(4):309-14. PubMed ID: 15777343
[TBL] [Abstract][Full Text] [Related]
15. Effects of hydroxyurea treatment on cerebral oxygenation in adult patients with sickle cell disease: an open-label pilot study.
Tavakkoli F; Nahavandi M; Wyche MQ; Castro O
Clin Ther; 2005 Jul; 27(7):1083-8. PubMed ID: 16154487
[TBL] [Abstract][Full Text] [Related]
16. Hematology patterns after hemoglobin-based oxygen carrier resuscitation from severe controlled hemorrhage with prolonged delayed definitive care.
Arnaud F; Fasipe D; Philbin N; Rice J; Flournoy WS; Ahlers S; McCarron R; Freilich D
Transfusion; 2007 Nov; 47(11):2098-109. PubMed ID: 17958540
[TBL] [Abstract][Full Text] [Related]
17. Resuscitation following severe, controlled hemorrhage associated with a 24 h delay to surgical intervention in swine using a hemoglobin based oxygen carrier as an oxygen bridge to definitive care.
Philbin N; Handrigan M; Rice J; McNickle K; McGwin G; Williams R; Warndorf M; Arnaud F; Malkevich N; McCarron R; Freilich D
Resuscitation; 2007 Aug; 74(2):332-43. PubMed ID: 17383073
[TBL] [Abstract][Full Text] [Related]
18. The apoptosis of blood polymorphonuclear leukocytes in sickle cell disease.
Ozdogu H; Boga C; Sozer O; Sezgin N; Kizilkilic E; Maytalman E; Yalcintas D
Cytometry B Clin Cytom; 2007 Jul; 72(4):276-80. PubMed ID: 17111385
[TBL] [Abstract][Full Text] [Related]
19. A comparison of the hemoglobin-based oxygen carrier HBOC-201 to other low-volume resuscitation fluids in a model of controlled hemorrhagic shock.
Sampson JB; Davis MR; Mueller DL; Kashyap VS; Jenkins DH; Kerby JD
J Trauma; 2003 Oct; 55(4):747-54. PubMed ID: 14566133
[TBL] [Abstract][Full Text] [Related]
20. Cytokine profile of sickle cell disease in Oman.
Pathare A; Al Kindi S; Alnaqdy AA; Daar S; Knox-Macaulay H; Dennison D
Am J Hematol; 2004 Dec; 77(4):323-8. PubMed ID: 15551290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
